Used primarily in research settings as an intermediate for synthesizing novel anthracycline derivatives with potential antitumor activity. Its bromine moiety allows for further chemical modifications, enabling the development of targeted cancer therapies. Shows utility in structure-activity relationship (SAR) studies to enhance cytotoxicity and reduce drug resistance in oncology drug design. Not used clinically but serves as a key compound in medicinal chemistry for exploring improved chemotherapeutic agents.